Rapid Affinity Characterization of Cell-Free Expressed Nanobodies Directly in Lysate with Biolayer Interferometry via Antigen-Immobilized Biosensors
ACS Synthetic Biology · 2026
DOI: 10.1021/acssynbio.6c00062 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Bret Lange und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biological Engineering, Iowa State University, Ames, Iowa 50011, United States. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Biosensing Techniques, Interferometry, Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, National Science Foundation.
Abstract (Originalsprache)
There have been a few recent works showing the advantages of combining cell-free protein expression (CFE) with biolayer interferometry (BLI) for the rapid kinetic characterization of novel capture proteins, such as nanobodies, to build out sequence-to-function data sets. Such data can inform iterative, machine-learning-guided models to optimize binding to a target antigen. In this work, we extend these approaches by presenting a new CFE-BLI workflow that flips the BLI binding orientation so that the target protein is immobilized on the biosensor surface and the CFE-expressed nanobody is measured directly in the lysate. This expands the applicability of CFE-BLI screening to encompass a larger set of nanobody-antigen pairs, such as multimeric target proteins. Our workflow utilizes a fluorogenic HaloTag fusion protein that enables precise protein quantification while also amplifying the BLI signal of smaller-molecular-weight binders like nanobodies. We test our workflow here using two previously characterized nanobodies (I3 and 2Rs15d) and show that our CFE-BLI screening method can calculate equilibrium dissociation constants (KD) similar to those previously reported. We further combine our workflow with a modern combinatorial mutagenesis workflow to screen 12 previously uncharacterized I3 nanobody mutants for improved affinity, demonstrating its potential use in rapid, high-iteration active-learning-guided protein engineering campaigns, especially on multimeric targets that may be presented in complex backgrounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biological Engineering, Iowa State University, Ames, Iowa 50011, United States.
- Protein Structure, Analysis, and Design Core, University of Iowa, Iowa City, Iowa 52242, United States.
- Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, Iowa 52242, United States.
- Department of Radiology, University of Iowa, Iowa City, Iowa 52242, United States.
ORCID-Profile: Thaddeus J Wadas, Nigel F Reuel
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Science Foundation
Zitieren
APA
Lange, B., Godin, R., Schnicker, N. J., Wadas, T. J., & Reuel, N. F. (2026). Rapid Affinity Characterization of Cell-Free Expressed Nanobodies Directly in Lysate with Biolayer Interferometry via Antigen-Immobilized Biosensors. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00062
Vancouver
Lange B, Godin R, Schnicker NJ, Wadas TJ, Reuel NF. Rapid Affinity Characterization of Cell-Free Expressed Nanobodies Directly in Lysate with Biolayer Interferometry via Antigen-Immobilized Biosensors. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.6c00062
BibTeX
@article{Lange2026,
author = {Lange, Bret and Godin, Ryan and Schnicker, Nicholas J and Wadas, Thaddeus J and Reuel, Nigel F},
title = {Rapid Affinity Characterization of Cell-Free Expressed Nanobodies Directly in Lysate with Biolayer Interferometry via Antigen-Immobilized Biosensors},
journal = {ACS Synthetic Biology},
year = {2026},
doi = {10.1021/acssynbio.6c00062}
}
EUVIMED